A case report of a probable drug-induced liver injury after therapy remodulation with lamotrigine, quetiapine and sertraline in an adult female with recurrent major depression using the updated RUCAM score

Drug-induced Liver Injury (DILI) is a common cause of acute liver injury and can be induced by several drugs. Lamotrigine, an antiepileptic drug, and quetiapine are used also as mood stabilizer medications and both have been reported to induce liver toxicity. The prescription of lamotrigine in assoc...

Full description

Saved in:
Bibliographic Details
Published in:Psychiatry research case reports 2024-12, Vol.3 (2), p.100232, Article 100232
Main Authors: Pistolesi, Chiara, Spaggiari, Riccardo, Finello, Veronica, Fortunato, Valeria, Polastri, Michele, Gaban, Alba, Palagini, Laura, Grassi, Luigi, Raparelli, Valeria, Passaro, Angelina, Simonato, Michele, Zuliani, Giovanni, D'Amuri, Andrea
Format: Article
Language:English
Subjects:
Antidepressants
Antiepileptics
Case report
Drug induced liver injury
Hepatotoxicity
RUCAM
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Drug-induced Liver Injury (DILI) is a common cause of acute liver injury and can be induced by several drugs. Lamotrigine, an antiepileptic drug, and quetiapine are used also as mood stabilizer medications and both have been reported to induce liver toxicity. The prescription of lamotrigine in association with other antidepressants can occur frequently in clinical practice, especially when depressive symptoms are resistant to monotherapy or are long-standing. The case we report highlights the likelihood of DILI with secondary liver damage due to the association between lamotrigine, quetiapine and sertraline through dose-dependent and not immune-mediated mechanisms. We present the case of a young adult female with recurrent major depression that, after dose remodulation of antidepressant therapy with lamotrigine, quetiapine and sertraline, experienced abdominal pain with evidence of acute liver injury. Liver damage went into remission after antidepressant therapy was discontinued. DILI appears as a probable explanation for these findings (6 points in items for hepatocellular injury in the updated RUCAM score) caused by the interaction between these drugs. This harmful effect is not yet well documented in the literature, and it seems to be due to a non-immune dose-dependent toxic effect. Caution is therefore warranted when prescribing the association of lamotrigine, quetiapine and sertraline.
ISSN:2773-0212
2773-0212
DOI:10.1016/j.psycr.2024.100232